Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Navin C Nanda

Showing results (361-370 of 369) with videos related to

Pageof 37
Sort By:
You have reached the last page of results.This site can display upto 369 results.
The Journal of the Association of Physicians of India|June 25, 2023
Angiotensin Receptor-Neprilysin Inhibitor Therapy and Cardiac Remodeling in Heart Failure: Consensus Statement from IndiaH K Chopra, G S Wander, Tiny Nair, et al.
Journal of Clinical Lipidology|March 14, 2024
Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: Consensus statement IVRaman Puri, Manish Bansal, Vimal Mehta, et al.
The Journal of the Association of Physicians of India|May 13, 2024
The Promise of Cilnidipine in Hypertension with Comorbidities: National Consensus Statement: National Consensus Group Comprises Cardiologists, Nephrologists, and Diabetologists from India in a National Meet at New Delhi held on 22<sup>nd</sup> May 2022Hirday Kumar Chopra, Gurpreet S Wander, Chandrashekhar K Ponde, et al.
The Journal of the Association of Physicians of India|June 24, 2023
The Power and Promise of Angiotensin Receptor Neprilysin Inhibitor (ARNI) in Heart Failure Management: National Consensus StatementH K Chopra, G S Wander, C K Ponde, et al.
The Journal of the Association of Physicians of India|June 17, 2024
Consensus Statement from India on the Renal Benefits of ARNi, SGLT-2i, and Bisoprolol in Chronic Kidney DiseaseH K Chopra, Dinesh Khullar, Tiny Nair, et al.
The Journal of the Association of Physicians of India|May 13, 2024
Role of Bisoprolol in Heart Failure Management: A Consensus Statement from IndiaH K Chopra, Tiny Nair, G S Wander, et al.
The Journal of the Association of Physicians of India|May 13, 2024
Current Place of SGLT2i in the Management of Heart Failure: An Expert Opinion from IndiaH K Chopra, Tiny Nair, G S Wander, et al.
The Journal of the Association of Physicians of India|September 18, 2024
Indian Consensus on the Role and Position of Angiotensin Receptor-neprilysin Inhibitors in the Management of Heart FailureHriday Kumar Chopra, Chandrashekhar Ponde, Gurpreet Singh Wander, et al.
The Journal of the Association of Physicians of India|June 24, 2025
National Consensus Statement on Role of Bisoprolol across Cardiovascular Continuum: Special Focus on WomenHriday Kumar Chopra, Kamal Kumar Sethi, Tiny Nair, et al.
Pageof 37

Showing results (361-370 of 369) with videos related to

Sort By:
Pageof 37
You have reached the last page of results.This site can display upto 369 results.
The Journal of the Association of Physicians of India|June 25, 2023
Angiotensin Receptor-Neprilysin Inhibitor Therapy and Cardiac Remodeling in Heart Failure: Consensus Statement from IndiaH K Chopra, G S Wander, Tiny Nair, et al.
Journal of Clinical Lipidology|March 14, 2024
Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: Consensus statement IVRaman Puri, Manish Bansal, Vimal Mehta, et al.
The Journal of the Association of Physicians of India|May 13, 2024
The Promise of Cilnidipine in Hypertension with Comorbidities: National Consensus Statement: National Consensus Group Comprises Cardiologists, Nephrologists, and Diabetologists from India in a National Meet at New Delhi held on 22<sup>nd</sup> May 2022Hirday Kumar Chopra, Gurpreet S Wander, Chandrashekhar K Ponde, et al.
The Journal of the Association of Physicians of India|June 24, 2023
The Power and Promise of Angiotensin Receptor Neprilysin Inhibitor (ARNI) in Heart Failure Management: National Consensus StatementH K Chopra, G S Wander, C K Ponde, et al.
The Journal of the Association of Physicians of India|June 17, 2024
Consensus Statement from India on the Renal Benefits of ARNi, SGLT-2i, and Bisoprolol in Chronic Kidney DiseaseH K Chopra, Dinesh Khullar, Tiny Nair, et al.
The Journal of the Association of Physicians of India|May 13, 2024
Role of Bisoprolol in Heart Failure Management: A Consensus Statement from IndiaH K Chopra, Tiny Nair, G S Wander, et al.
The Journal of the Association of Physicians of India|May 13, 2024
Current Place of SGLT2i in the Management of Heart Failure: An Expert Opinion from IndiaH K Chopra, Tiny Nair, G S Wander, et al.
The Journal of the Association of Physicians of India|September 18, 2024
Indian Consensus on the Role and Position of Angiotensin Receptor-neprilysin Inhibitors in the Management of Heart FailureHriday Kumar Chopra, Chandrashekhar Ponde, Gurpreet Singh Wander, et al.
The Journal of the Association of Physicians of India|June 24, 2025
National Consensus Statement on Role of Bisoprolol across Cardiovascular Continuum: Special Focus on WomenHriday Kumar Chopra, Kamal Kumar Sethi, Tiny Nair, et al.
Pageof 37